Tocriscreen FDA-Approved Drugs Library
Tocris Bioscience a Bio-Techne Brand
Key Product Details
Description: | Drug repurposing library; a library of 190 compounds equivalent to active components of drug formulations approved by the FDA (100 μL 10 mM DMSO solutions) |
Key Format Details: |
![]() The Tocriscreen FDA-approved Drugs Library contains bioactive compounds covering a diverse range of therapeutic classifications, derived using the WHO Anatomical Therapeutic Chemical Classification System code (ATC code). |
Customers also Viewed
Citations for Tocriscreen FDA-Approved Drugs Library (4)
Citations are publications that use Bio-Techne products. Selected citations for Tocriscreen FDA-Approved Drugs Library include:
-
Edmister et al.
(2022)
Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles.
Sci.Rep..
12:6120
PMID: 35449173 -
Gull et al.
(2022)
Screening of chemical libraries using xenopus embryos and tadpoles for phenotypic drug discovery.
Cold Spring Harb.Protoc..
2022;
PMID: 36180216 -
Mehyar et al.
(2020)
Using in silico modelling and FRET-based assays in the discovery of novel FDA-approved drugs as inhibitors of MERS-CoV helicase.
SAR QSAR Environ Res.
6:1
PMID: 33401979 -
Shin et al.
(2018)
Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro.
Viruses.
10:E283
PMID: 29795047
There are no citations that match your criteria.